Pluvicto can now be used before chemotherapy to treat a kind of metastatic prostate cancer, tripling the number of patients ...
By Paul Arnold and Maggie Fick ZURICH (Reuters) -Swiss drugmaker Novartis is ending its use of diverse panels for all of its ...
14h
Zacks Investment Research on MSNHere's Why Novartis (NVS) is a Strong Value StockFor new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. Featuring daily updates ...
After much delay, Novartis has finally won a key FDA go-ahead for Pluvicto, opening up the radioligand therapy to a much ...
10d
Daily Voice on MSNPharma Giant Cutting 400+ More East Hanover Jobs Ahead Of Major Drug Patent's ExpirationPharmaceutical company Novartis is laying off more than 400 employees at its East Hanover facility as part of a restructuring ...
On Wednesday, Novartis gave a more detailed look at long-awaited clinical data that the company believes will help secure a ...
Last year, Novartis agreed to buy U.S.-based Mariana Oncology for ... Autos & Transportationcategory Trump's auto tariffs will hit many companies, but Elon Musk's Tesla less so 9:48 PM UTC · Updated ...
This is the third indication for Fabhalta after Novartis won FDA approval of the small molecule in paroxysmal nocturnal ...
The World Business Council for Sustainable Development (WBCSD), in collaboration with leading pharmaceutical companies and ...
The notice comes three months after the pharmaceutical giant said it would eliminate 139 jobs at the location between February and August.
Novartis was announced as an official partner of this year’s Eurovision competition last fall, after the song entry from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results